Facial diplegia after pembrolizumab treatment.

Yost, Micah D

Facial diplegia after pembrolizumab treatment. [electronic resource] - Muscle & nerve 09 2017 - E20-E21 p. digital

Publication Type: Case Reports; Journal Article

1097-4598

10.1002/mus.25663 doi


Antibodies, Monoclonal, Humanized--adverse effects
Antineoplastic Agents, Immunological--adverse effects
Facial Paralysis--chemically induced
Humans
Male
Middle Aged